Blood Substitutes
Phase III Trials of PolyHeme Initiated
Published in Hepatitis Weekly, September 22nd, 1997
The randomized, controlled study is expected to take approximately 12 months and will include 240 patients, at approximately 20 facilities nationwide, who receive up to six units of PolyHeme (equivalent to six pints of blood). These advanced trials are the first Phase III study by any company to include direct replacement of blood in large volumes.
"We are pleased to have our first sites ready to begin enrollment," said Richard DeWoskin, Northfield Laboratories,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1997-09-22)
More Articles from Hepatitis Weekly
- Transmission (HCV)
Sexually Acquired HCV Prevented with Immune Globulin - Blood Banking (Hepatitis)
High Prevalence Found Among Male Blood Donors in Northeast Thailand - Coinfection (HBV/HCV)
IFN Could Be Harmful in Dually Infected - Coinfection (Hepatitis/HIV)
Survival Reduced in HIV Patients with HCV or HBV Infection - Conference Coverage (ISV)
International Society for Vaccines Seeks To "Jump Start Vaccine Era" - Conference Coverage (ISV)
Which Multicomponent Vaccine? CDC Has Selection Algorithm - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
